NR1H4 and obesity due to melanocortin 4 receptor deficiency: Subsequent preclinical studies have further elaborated on this pathway [32–34], while several recent clinical trials have solidified the perceived role of bile acid-FXR-FGF19 signaling in obesity [35–37].